Foundation Healthcare Holdings (FRA:C5Y) Debt-to-EBITDA : N/A (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:C5Y Foundation Healthcare Holdings Ltd FRA:C5Y
16 GF Score
Price €0.41
! 3 Warning Signs
View Full Analysis

What is Foundation Healthcare Holdings Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Foundation Healthcare Holdings's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2026 was €17.2 Mil. Foundation Healthcare Holdings's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2026 was €212.9 Mil. Foundation Healthcare Holdings's annualized EBITDA for the quarter that ended in Jun. 2026 was €0.0 Mil.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Foundation Healthcare Holdings's Debt-to-EBITDA or its related term are showing as below:

During the past 3 years, the highest Debt-to-EBITDA Ratio of Foundation Healthcare Holdings was 7.77. The lowest was 3.28. And the median was 3.58.

FRA:C5Y's Debt-to-EBITDA is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 2.18
* Ranked among companies with meaningful Debt-to-EBITDA only.

Foundation Healthcare Holdings  (FRA:C5Y) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

Foundation Healthcare Holdings Debt-to-EBITDA Related Terms

Foundation Healthcare Holdings Debt-to-EBITDA Historical Data

* Premium members only.

The historical data trend for Foundation Healthcare Holdings's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Foundation Healthcare Holdings Debt-to-EBITDA Chart

Foundation Healthcare Holdings Annual Data
Trend Dec23 Dec24 Dec25
Debt-to-EBITDA
7.77 3.28 3.58

Foundation Healthcare Holdings Quarterly Data
Dec23 Dec24 Dec25 Jun26
Debt-to-EBITDA N/A N/A N/A N/A

FRA:C5Y vs HCA, THC, EHC: Debt-to-EBITDA Comparison

For the Medical Care Facilities subindustry, Foundation Healthcare Holdings's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Foundation Healthcare Holdings Debt-to-EBITDA vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Foundation Healthcare Holdings's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Foundation Healthcare Holdings's Debt-to-EBITDA falls into.


FRA:C5Y
16GF Score
Foundation Healthcare Holdings Ltd FRA:C5Y
Debt-to-EBITDA is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Foundation Healthcare Holdings Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Foundation Healthcare Holdings's Debt-to-EBITDA for the fiscal year that ended in Dec. 2025 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(16.039 + 214.248) / 64.314
=3.58

Foundation Healthcare Holdings's annualized Debt-to-EBITDA for the quarter that ended in Jun. 2026 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(17.152 + 212.906) / 0
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Jun. 2026) EBITDA data.

Foundation Healthcare Holdings Business Description

Other Exchanges FHH:Singapore
Address 238A Thomson Road, No. 13-10 Novena Square, Singapore, SGP, 307684
Foundation Healthcare Holdings Ltd is an integrated private healthcare platform that connects medical specialists, healthcare providers, payors, patients and facilities across the healthcare ecosystem in Singapore. The company has two reportable business segments: (i) medical specialists and (ii) others, which comprise the medical centres and technology platform. The majority of revenue is derived from the Medical Specialists segment, which generates revenue from consultation fees, medical procedures (such as surgeries) performed by the medical specialists in medical facilities, and sales of drugs and consumables. Geographically, the company's operations are solely in Singapore.
16GF Score

Get the complete analysis for FRA:C5Y

Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.41
Price